Product
Product Name: Retatrutide
Minimum Order: 10 vials/box,
Payment: T/T, Bitcoin, Western Union, Credit Card, Bank Transfer, PayPal,Alibaba, Alipay, Wechat,Wise
Delivery: 1000000 boxes/week
Delivery: Ships immediately after payment received
Regular packing: 5mg/vial, 10mg/vial, 15mg/vial, 20mg/vial, 30mg/vial
Retatrutide is a novel triple agonist of GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulin-stimulating peptide) and glucagon receptor. As a multi-target hypoglycemic drug, it significantly improves blood glucose control, promotes weight loss, and may bring multiple benefits to cardiovascular metabolism by simultaneously activating three enteroinsulin-stimulating receptors.
Mechanism of Action
Exert a combined effect by activating three receptors:
1.GLP-1 receptor: Enhances insulin secretion, inhibits glucagon, delays gastric emptying, and increases satiety.
2.GIP receptor: Improves insulin sensitivity and regulates energy metabolism.
3.Glucagon receptor: Promotes fat breakdown and increases energy expenditure.
Product advantages
1.Triple excitation mechanism: Simultaneously activate GLP-1, GIP and glucagon receptors to synergistically regulate metabolism.
2.Highly effective hypoglycemic effect: Significantly reduces the blood glucose level (HbA1c) of patients with type 2 diabetes mellitus (T2DM).
3.Significant weight loss: Clinical data show that the weight loss effect is superior to that of single/double receptor agonists (such as semaglutide and tielpotide).
4.Comprehensive improvement of metabolism: Potential benefits include lowering blood lipids, improving fatty liver and providing cardiovascular protection.
Hot Tags: glp weight loss peptide retatrutide 5mg, China glp weight loss peptide retatrutide 5mg manufacturers, suppliers, factory, compound pharmacy semaglutide, generic semaglutide compounding pharmacy, peptides for weight loss and muscle gain, semaglutide online pharmacy, semaglutide with b12, weight loss drug semaglutide